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Objective: Metabolic syndrome (MetS) and its associated cardiovascular risk are on the 
increase in children. High-sensitivity C-reactive protein (hs-CRP) has emerged as a useful 
marker for inflammation associated with atherosclerosis and cardiovascular disease. Our aim 
was to determine the distribution of hs-CRP in an effort to identify the MetS variable that is 
critical in modulating plasma CRP levels in a population of South African adolescents.
Design: A cross-sectional analytical study design was used for this investigation, where the 
dependent and independent variables were measured simultaneously.
Methods: Anthropometric variables, blood pressure, fasting blood glucose and lipids were 
performed on 324 consenting learners aged 15–18 years from three different ethnic groups 
(Black, White and Coloured). The National Cholesterol Education Program Adult Treatment 
Panel III (NCEP ATP III) for ages 15–18 year olds was used to define MetS. 
Results: The prevalence of MetS and obesity was 3.7% and 7.1%, respectively. The hs-CRP 
levels were significantly higher in subjects with a waist-circumference greater than the 90th 
percentile (p < 0.01) and in obese learners with MetS, but was lower in adolescents with normal 
weight and MetS. Median hs-CRP levels increased with an increasing number of metabolic 
abnormalities and exceeded 3 mg/L in 19% of adolescents. Gender and ethnic differences were 
observed.
Conclusion: Our findings suggest that obesity and waist circumference appear to be major 
mediators of hs-CRP levels in South African adolescents. 
© 2012. The Authors.
Licensee: AOSIS 
OpenJournals. This work
is licensed under the
Creative Commons
Attribution License.
Introduction
Globally, obesity and its accompanying metabolic complications are on the increase. Childhood 
obesity has reached epidemic proportions and is one of the most serious public health problems 
facing the developed and, increasingly, the developing world.1 Metabolic syndrome (MetS), a 
constellation of interrelated conditions of insulin resistance, hyperlipidaemia, hypertension and 
obesity, is one of the recognised complications or associations of obesity. A pro-inflammatory 
and pro-thrombotic state contributing to endothelial dysfunction is a common feature of those 
with MetS.2 It is well recognised that inflammation plays a key role in the pathophysiology of 
atherosclerosis and cardiovascular disease (CVD).3 
Markers of endothelial dysfunction and inflammation include tumour necrosis factor-alpha 
(TNF-α), the interleukins (IL) and C-reactive protein (CRP). TNF-α is a cytokine secreted from 
endothelial and smooth muscle cells, macrophages and fat cells. It enhances monocyte recruitment 
into developing atherosclerotic lesions and therefore links obesity with atherosclerosis.4 IL-6 is 
the major pro-coagulant cytokine. It increases plasma levels of plasminogen activator inhibitor 
type 1, fibrinogen and CRP. Lifestyle modifications, including a Mediterranean-style diet and 
weight loss, reduce serum concentrations of IL-6, IL-7, and IL-18.5 Patients with coronary heart 
disease have markedly elevated levels of IL-1, especially those with unstable disease.6
 
Pro-inflammatory cytokines, including IL1-β, IL-6 and TNF-α, are released from macrophages 
within the vessel wall during an inflammatory response.4 These cytokines mediate distant 
inflammatory effects, including activation of hepatic genes encoding acute-phase reactants, CRP, 
fibrinogen and serum amyloid A. CRP induces synthesis of other cytokines, cellular adhesion 
molecules (CAMs) and tissue factor in monocytes and endothelial cells.4,7 Tissue factor activation 
provides the link between inflammation and coagulation by activating the coagulation cascade.
CRP was traditionally measured in patients to assess and monitor systemic inflammation during 
an acute infection. Values exceeding 10 mg/L are accepted as evidence of probable infection 
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and/or sepsis. The need for detection very low levels 
(< 3 mg/L) only became necessary when CRP was discovered 
to be a useful marker of endothelial dysfunction and future 
CVD risk. High-sensitivity C-reactive protein (hs-CRP) has 
emerged as a useful biomarker for vascular inflammation 
associated with atherosclerosis and it may directly promote 
atherosclerotic processes.8,9 As such, elevated hs-CRP levels, 
as a response to the increase in the secretion of cytokines of 
adipose origin, have been used as a marker of cardiovascular 
risk and diabetes in adults.10 Various hs-CRP methods have 
been introduced, fulfilling the need of measuring CRP levels 
at these low levels. In apparently healthy adults, hs-CRP 
levels of more than 3 mg/L are associated with a high risk of 
future CVD.
Many studies have examined the clustering of metabolic 
abnormalities, but the metabolic phenotype continues to 
be less well understood in children in terms of criteria, 
prevalence and clinical implications.11 Studies have 
reported high values of hs-CRP amongst obese children and 
adolescents, indicating a certain level of inflammation.3,12 
Childhood CRP values have also been shown to predict 
adult CRP levels independently of other metabolic risk 
factors.13 The US National Health and Nutrition Examination 
Survey (USNHANES) reported that adolescents with more 
metabolic abnormalities had higher CRP levels.11
The few studies conducted in developing countries have 
shown a relatively high prevalence of MetS that is paralleled 
by the increasing obesity in children and adolescents.14 
A recent study on the prevalence of MetS amongst South 
African children reported an overall rate of 6.5% using 
the National Cholesterol Education Program expert panel 
on detection, evaluation and treatment of high blood 
cholesterol – Adult Treatment Panel III (NCEP ATP III) 
definition.15 In South Africa, morbidity and mortality related 
to non-communicable disease remain prominent, despite the 
sustained increase in deaths from chronic infections such 
as HIV and AIDS and tuberculosis.16,17 This is particularly 
important when providing interventions that target CVD 
and their risk factors, as these chronic conditions place a 
huge financial and human resource burden on South Africa’s 
health budget. The measurement of hs-CRP concentrations 
may thus provide an indication of future risk of CVD, which 
may lead to earlier intervention.
Therefore, the aim of this study was to determine the 
distribution of hs-CRP in a population of South African 
adolescent learners and to determine its association with 
cardiovascular risk factor variables of MetS, in an effort to 
identify the variable that is critical in modulating plasma hs-
CRP levels in this population.
Materials and methods
Subjects
Our study population formed part of a larger study 
involving 1683 learners aged 8–18 years, recruited through 
a proportionally stratified multistage random sampling 
technique from government-funded secondary schools in the 
Western Cape Province of South Africa. The inclusion criteria 
were, (1) male or female learners aged 15 years – 18 years, (2) 
fasted overnight (≥ 10 h) and (3) no current or recent history 
of infectious disease (on self-report). Participants were 
excluded if the measured hs-CRP values were > 10 mg/L, 
or if there were any missing data. Recent and/or current 
infectious disease was excluded by self-report and brief 
medical examination on the day of sampling. 
Measurement of blood pressure, glucose and 
lipids
Finger prick blood performed by trained nursing staff 
was used for the estimation of fasting blood glucose (FBG) 
and lipid levels using the Accutrend GCT glucometer and 
CardioChekTM PA analyser (Polymer Technology Systems, 
Inc., Indianapolis, USA), respectively. The glucometer 
coefficient of variation is stated as < 3% and accuracy 
is approximately 5%, when compared to a hexokinase 
method. The CardiochekTM analyser showed reasonable 
compliance with NCEP goals for coefficients of variation and 
bias measurements.18 Blood pressure measurements were 
performed using a semi-automatic digital blood pressure 
monitor (Rossmax Int. Ltd, Taipei, Taiwan) according to 
World Health Organization guidelines.19 The NCEP ATP III 
for ages 15–18 years were used to define MetS20 (Table 1). 
Individuals were classified as overweight or obese, according 
to age and gender, as described by Cole et al.21
Measurement of hs-CRP 
Different platforms exist to measure hs-CRP, including 
turbidimetric, nephelometric and immunometric assays 
(two-site chemiluminescent). These different methodologies 
compare well in precision and comparative studies.22 
Venous blood was collected and the serum was separated 
and frozen at -20 °C before batch analysis. The hs-CRP was 
measured by an hs-CRP assay, based on the highly sensitive 
Near Infrared Particle Immunoassay rate methodology 
(Immage® Immunochemistry System, Beckman Coulter 
Inc., Brea, USA), with an analytical sensitivity of 0.2 mg/L 
and a functional sensitivity of 0.11 mg/L (measuring range 
0.2 mg/L – 1440 mg/L). Participants with hs-CRP concentrations 
< 0.2 mg/L had a value assigned to them of 0.2 mg/L.
Statistical analysis
The STATISTICA 8 software package (StratSoft Inc., Tulsa, 
USA) was used to perform statistical analyses. Descriptive 
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TABLE 1: Criteria for the metabolic syndrome are listed below and can be any 
three of more.
Criteria list Components
Central obesity† > 90th percentile, age and gender specific
FBG ≥ 5.6 mmol/L (100 mg/dL) or known type 2 diabetes
Hypertension ≥ 90th percentile for age, sex and height
TG ≥ 1.24 mmol/L (110 mg/dL)
HDL-C ≤ 1.04 mmol/L (40 mg/dL)
Source: Cook S, Weitzman M, Auinger P, Nguyen M, Dietz WH. Prevalence of a metabolic 
syndrome phenotype in adolescents. Arch Pediatr Adolesc Med. 2003;157:821–827.
FBG, fasting blood glucose; TG, triglycerides; HDL-C, high density lipoprotein cholesterol.
†, Waist circumference. 
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data are represented as medians because hs-CRP has a non-
Gaussian distribution and non-parametric statistics have 
been applied. Other variables, such as glucose, triglycerides 
and cholesterol, are presented as means, as they follow a 
normal distribution. For categorical data, group comparisons 
were performed using the Mann Whitney U-test. A 5% 
significance level (p < 0.05) was used for determining 
significant differences. 
Ethical considerations
The study was approved by the Faculty of Health Science 
Ethics Committee at the University of Stellenbosch and 
consent to conduct the study was obtained from the Western 
Cape Education Department. Ethical clearance was given for 
the collection of venous blood samples from the participants 
older than 12 years. Finally, a parent or guardian gave 
consent for the adolescents’ participation in this study and 
the participants themselves assented.
Results
Three-hundred-and-twenty-nine learners who satisfied the 
inclusion criteria were recruited for the study. Five were 
then excluded from this initial study population as a result of 
hs-CRP levels > 10 mg/L, leaving 324 learners for this study. 
Of this total, 186 (57.4%) were female, whilst 138 (42%) were 
male. The final study population comprised 136 (42%) Black 
learners, 62 (19%) White learners and 126 (39%) Coloured 
learners.
The distribution of hs-CRP was skewed, with higher median 
hs-CRP concentrations in female learners than male learners 
(1.77 mg/L vs 1.39 mg/L, respectively; p = 0.15). Significant 
racial differences were observed with higher median hs-CRP 
levels in non-White learners (White – 1.02 mg/L; Black – 
1.74 mg/L; Coloured – 1.76 mg/L). The hs-CRP levels 
correlated positively with the learners’ body mass index 
(BMI) and waist circumference, but not with high density 
lipoprotein cholesterol (HDL-C) or triglycerides. 
The prevalence of MetS and obesity was 3.7% and 7.1%, 
respectively. Obesity was higher in all female learners, whilst 
Coloured learners (17%) had a nearly three times higher rate 
of obesity than White learners (5%) or Black learners (4%).
The median hs-CRP levels in the MetS group were 2.56 mg/L, 
compared to 1.67 mg/L in those without MetS. The hs-CRP 
values correlated positively with an increase in the number 
of MetS components present (Figure 1). Four (33%) subjects 
with MetS had a normal weight and their median hs-CRP 
levels were significantly lower than the obese group (Table 
2). Because low-grade systemic inflammation may underlie, 
at least in part, the clustering of metabolic risk factors, we 
examined the relationship between hs-CRP concentrations 
and components of the MetS. There was no association 
between the individual components, blood pressure, 
triglycerides, fasting blood glucose and hs-CRP noted. More 
than 60% of the participants had HDL values below the cut-
off of 1.04 mmol/L, with a mean value 0.97 mmol/L.
There was a significant difference (p < 0.01) noted in the 
CRP concentrations between those with a normal waist 
circumference, compared to those with a waist circumference 
greater than the 90th percentile (1.39 mg/L vs 3.22 mg/L, 
respectively). 
The hs-CRP levels of > 3 mg/L were seen in 18.5% (n = 60) 
of learners. Table 3 compares baseline demographic data 
and laboratory values for children with CRP levels of 
≥ 3 mg/L and those with CRP levels of < 3 mg/L. These subjects 
were likely to have higher BMIs, with a higher percentage of 
obese subjects. However, 13% (n = 33) of children with levels 
> 3 mg/L had normal BMI. 
Discussion
Inflammation is an important pathogenic factor in the 
development of atherosclerosis and coronary heart disease, 
especially in those with diabetes, obesity and MetS. An 
important asset of our study is that it investigated the 
prevalence of MetS in adolescents from three different racial 
groups in South Africa. MetS, as defined by the modified 
NCEP ATP III classification, was observed in 3.7% of all 
children, with hs-CRP values nearly three times higher in 
children with MetS compared to those without it.20 Previous 
studies have reported that hs-CRP concentrations correlate 
with individual components of the MetS.11 We observed a 
positive linear trend in hs-CRP levels, with an increasing 
number of features of MetS. We also observed no association 
between the individual components: blood pressure, 
triglycerides, fasting blood glucose and hs-CRP. Of the 
TABLE 2: Metabolic syndrome, body mass index (BMI) and high-sensitivity 
C-reactive protein (hs-CRP) levels amongst the study participants (N = 324).
BMI N Hs-CRP (mg/L) Subjects (> 3 components)
Number Median hs-CRP (mg/L)
Normal 
Overweight
Obese
251
50
23
1.28
2.12
4.00
4
1
7
0.65
0.60
3.94
Total 324 1.61 12 –
  
FIGURE 1: Association between the number of metabolic components and high-sensitivity 
C-reactive protein (Hs-CRP).  
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FIGURE 1: Association between the number of metabolic components and 
high-sensitivity C-reactive protein (Hs-CRP).
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metabolic variables studied, adiposity, as measured by BMI 
and waist circumference, was the major predictor of hs-CRP 
(similar to results obtained from international studies3,11), 
suggesting obesity as a mediator of excess CRP seen in the 
MetS. MetS has been associated with higher CRP levels even 
in the absence of obesity,3,11,23 but this was not observed in 
our study. Considerably lower hs-CRP levels were observed 
in children with MetS but with normal weight (also termed 
metabolically obese, normal-weight children), with the 
median hs-CRP in this group being 0.65 mg/L, compared to 
3.9 mg/L in the obese group. Previous studies have suggested 
that metabolically obese but normal-weight individuals are 
also at an increased risk of developing type 2 diabetes and 
CVD24; however, this needs to be explored further in our 
setting in the light of these observations.
This community-based study has demonstrated that hs-
CRP levels in South African children vary by race and sex 
and relate adversely to risk variables of MetS. The hs-CRP 
values ranged from 0.2 mg/L to 9.9 mg/L, with higher median 
hs-CRP concentrations in female learners (1.77 mg/L vs 
1.39 mg/L). Similar observations have been made by Lambert 
et al.23 in 16-year-old children from Quebec, Canada, as well 
as in the 1999–2000 US NHANES11 and the Bogalusa studies3. 
However, in the Taipei Children Heart Study of CRP 
concentrations no gender differences were observed.25 Sex 
differences have been attributed to the effect of estrogens, 
which have been implicated in the transcriptional control 
and clearance of hs-CRP.26 
As observed in adults,27 we found that there were also ethnic 
differences, with Black and Coloured children having higher 
hs-CRP levels. Ethnic differences in body fat patterning are 
thought to account for some of the observed differences.28 In 
the Bogalusa study, hs-CRP levels showed racial differences 
and related to measures of obesity.3 For a given waist 
circumference, Black boys and girls from the USA were 
found to have higher abdominal subcutaneous adipose tissue 
and lower visceral adipose tissue than their White peers.28 
Similar observations have been reported in South African 
children, in whom relatively more subcutaneous fat and 
greater waist circumference have been observed in stunted 
girls, which may predispose them to obesity in adulthood.29 
In the Strong Without Anorexia Nervosa (SWAN) study, 
which examined 3154 women from different ethnic groups, 
Afro-American ethnicity was associated with higher hs-CRP 
levels after controlling for BMI, age and other risk factors, 
suggesting that genetic variants of hs-CRP and dietary and 
lifestyle factors could also be contributory factors.27,30 The 
implications of these elevated hs-CRP levels need further 
study, as South African Black people generally have a better 
cardiovascular risk profile than other ethnic groups.
Obesity rates were comparable to those observed in many 
developed countries and obese learners in our study had 
a significantly higher median hs-CRP (4.00 ± 0.58 mg/L) 
compared to their normal-weight counterparts (1.28 
± 0.12 mg/L). Because fat distribution appears to have a more 
important influence on cardiovascular risk factors in young 
subjects than overall adiposity, abdominal obesity has been 
identified as the main determinant of several metabolic 
disorders.31,32 The relationship of waist circumference as a 
measure of abdominal obesity appears to be explained by 
its strong association with visceral adipose tissue, therefore 
explaining the strong association with inflammatory 
biomarkers such as hs-CRP.33 We compared the hs-CRP 
concentration of those with a normal waist circumference to 
those individuals with a waist circumference greater than the 
90th percentile and, as expected, found a significant difference 
(p < 0.01). This finding is consistent with international results 
and highlights that an increase in abdominal obesity mirrors 
visceral adiposity and increased inflammation.33 Waist 
circumference, particularly in young South African women, 
has been shown to be a better predictor of insulin resistance 
than visceral adipose tissue.34 
Whilst these results re-affirm that high hs-CRP values are 
most likely caused by increased fat deposition, we also 
observed that more than half of the children with hs-CRP 
> 3 mg/L were of normal weight, suggesting that a sizable 
number of apparently healthy children may be at increased 
cardiovascular risk. Despite these observations in this and 
other studies, it is not recommended for hs-CRP to be a 
suitable target for therapeutic intervention as no causal 
association between hs-CRP and MetS phenotypes has 
been reported.35 One platform to measure CRP, regardless 
TABLE 3: Baseline demographic data and laboratory results of the study participants (N = 324).
Category Sub-category hs-CRP < 3 mg/L hs-CRP ≥ 3 mg/L p-Value
Gender Male
Female
117 (85%)
147 (79%)
21 (15%)
39 (21%)
–
–
Race Coloured
Black
White
99 (79%)
111 (82%)
54 (87%)
27 (21%)
25 (18%)
8 (13%)
–
–
–
Body mass index Normal
Overweight
Obese
218 (87%)
37 (74%)
9 (39%)
33 (13%)
13 (26%)
14 (61%)
–
–
–
Fasting blood glucose (mmol/L) Mean 3.86 4.25 < 0.01
HDL (mmol/L) Mean 0.97 0.99 0.68
Triglycerides (mmol/L) Mean 0.82 0.77 0.39
Waist circumference < 90th percentile
> 90th percentile
244 (85%)
20 (53%)
42 (15%)
18 (47%)
< 0.01
hs-CRP, high-sensitivity C-reactive protein; HDL, high density lipoprotein.
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of the clinical context, is ideal in the clinical laboratory as 
it could lead to decreased cost and turn-around-time of 
analysis, as most laboratories have dedicated instruments 
for measurement of hs-CRP and batch-analysis is usually 
performed. 
There are several limitations to our findings. The primary 
limitation is the use of a single hs-CRP measurement. In 
adults, repeat hs-CRP measurements are recommended, 
as concentrations are affected by factors such as recent 
infection and inflammatory conditions. The measurement of 
other inflammatory biomarkers of endothelial dysfunction 
could have added more value to the study. Other tests that 
could have excluded active infection, for example cytokines 
or white blood cell count, were not conducted. A second 
limitation is that this was not a national study and excluded 
learners from private schools. Another limitation is that 
the study outcomes depended on the definition of MetS. 
Insulin resistance, the key component of the MetS, was not 
determined. Furthermore, direct measurement of body fat 
mass and distribution was not assessed and the study was 
observational and cross-sectional in nature, making it difficult 
to differentiate between cause and effect, and associations. 
In summary, we have found that hs-CRP is increased in 
South African adolescents with metabolic abnormalities and 
the MetS phenotype. Markers of adiposity, such as BMI and 
waist circumference, appear to be strong mediators of hs-CRP 
and many learners had hs-CRP levels greater than 3 mg/L, a 
value that has been used in adults to indicate high CVD risk. 
In our setting, hs-CRP may be useful marker to assess early 
atherosclerosis and cardiovascular risk, particularly in those 
children with normal BMI. 
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